{
    "code": "02024557",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024557",
    "time": "2018-03-30 03:47:58",
    "許可證字號": "衛署藥輸字第024557號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/02\/12",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "105\/11\/06",
    "發證日期": "95\/11\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202455709",
    "中文品名": "喜普樂 靜脈輸液 2毫克\/毫升",
    "英文品名": "Ciprofloxacin Claris IV Infusion 0.2% w\/v",
    "適應症": "成人：對CIPROFLOXACIN有感受性之細菌所引起之呼吸道感染、中耳炎、竇炎、眼感染、腎臟及泌尿道感染（包括淋病）、腹部感染（包括腸炎、膽囊炎、腹膜炎）、皮膚及軟組織感染、骨髓炎、關節感染等、菌血症、吸入性炭疽病(接觸後)。小孩︰綠膿桿菌有關之囊腫性纖維化產生急性肺部惡化的現象(5-17歲)、吸入性炭疽病(接觸後)。",
    "劑型": "270注射劑",
    "包裝": "50\/100\/200毫升玻璃小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CIPROFLOXACINLACTATE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201010653  安強藥業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200135000  CLARIS INJECTABLES LIMITED",
        "製造廠廠址": "CHACHARWADI-VASANA, SANAND AHMEDABAD, GUJARAT. 382 213, INDIA",
        "製造廠公司地址": ""
    },
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700720",
            "成分名稱": "CIPROFLOXACIN LACTATE",
            "含量描述": "",
            "含量": "2.5440000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "喜普樂仿單20131230-103-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024557&Seq=010&Type=9"
        },
        {
            "title": "喜普樂標籤圖檔___20120523.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024557&Seq=014&Type=8"
        }
    ]
}